Decline of plasma 5α-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels

Andrologia

Volumn 40, Issue 5, 2008, Pages 298-302

  Gooren, L J ^a   Saad, F ^b,c   Haide, A ^d   Yassin, A ^c,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BAYER PHARMA AG   (Germany)

^c GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^d Private Urology Prxis   (Germany)

^e Segeberger Kliniken   (Germany)

Author keywords

5 dihydrotestosterone; 5 reductase; Late onset hypogonadism; Testosterone treatment

Indexed keywords

ANDROSTANOLONE; SEX HORMONE; TESTOSTERONE; CHOLESTENONE 5ALPHA REDUCTASE; DRUG DERIVATIVE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; HORMONE BLOOD LEVEL; HUMAN; AGING; BLOOD; CLINICAL TRIAL; HYPOGONADISM; MALE; METABOLISM; MIDDLE AGED;

AGING; CHOLESTENONE 5 ALPHA-REDUCTASE; DIHYDROTESTOSTERONE; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 51649120428     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2008.00857.x     Document Type: Article

References (26)

1. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D (1999) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 84 : 573 577.
2. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab 89 : 2179 2184.
3. Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Despres JP, Bouchard C (2000) Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J Clin Endocrinol Metab 85 : 1026 1031.
4. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA (1999) Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 84 : 3469 3478.
5. Dobs AS, Matsumoto AM, Wang C, Kipnes MS (2004) Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men. Curr Med Res Opin 20 : 729 738.
6. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87 : 589 598.
7. George FW, Russell DW, Wilson JD (1991) Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase. Proc Natl Acad Sci USA 88 : 8044 8047.
8. Iranmanesh A, Veldhuis JD (2005) Combined inhibition of types I and II 5 alpha-reductase selectively augments the basal (nonpulsatile) mode of testosterone secretion in young men. J Clin Endocrinol Metab 90 : 4232 4237.
9. Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26 : 833 876.
10. Kunelius P, Lukkarinen O, Hannuksela ML, Itkonen O, Tapanainen JS (2002) The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. Clin Metab Endocrinol J 87 : 1467 1472.
11. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91 : 843 850.
12. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ (2001) A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86 : 4078 4088.
13. Nieschlag E (2006) Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol (Oxf) 65 : 275 281.
14. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90 : 1502 1510.
15. Pratis K, O'Donnell L, Ooi GT, McLachlan RI, Robertson DM (2000) Enzyme assay for 5alpha-reductase type 2 activity in the presence of 5alpha-reductase type 1 activity in rat testis. J Steroid Biochem Mol Biol 75 : 75 82.
16. Russell DW, Wilson JD (1994) Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem 63 : 25 61.
17. Sakhri S, Gooren LJ (2007) Safety aspects of androgen treatment with 5alpha-dihydrotestosterone. Andrologia 39 : 216 222.
18. Schubert M, Minnemann T, Hubler D, Rouskova D, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhovel F (2004) Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab 89 : 5429 5434.
19. Sparrow D, Bosse R, Rowe JW (1980) The influence of age, alcohol consumption, and body build on gonadal function in men. J Clin Endocrinol Metab 51 : 508 512.
20. Steers WD (2001) 5alpha-reductase activity in the prostate. Urology 58 : 17 24.
21. Swerdloff RS, Wang C (2003) Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. Aging Male 6 : 207 211.
22. Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 85 : 4500 4510.
23. Toorians AW, Kelleher S, Gooren LJ, Jimenez M, Handelsman DJ (2003) Estimating the contribution of the prostate to blood dihydrotestosterone. J Clin Endocrinol Metab 88 : 5207 5211.
24. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89 : 2085 2098.
25. Wilson JD (1996) Role of dihydrotestosterone in androgen action. Prostate Suppl 6 : 88 92.
26. Wilson JD (2001) The role of 5alpha-reduction in steroid hormone physiology. Reprod Fertil Dev 13 : 673 678.